Use of Ayurvedic Manjishtadi Lotion to Prevent and Treat Striae Gravidarum (stretch marks of pregnancy)
- Conditions
- Primi-gravida
- Registration Number
- CTRI/2025/06/089331
- Lead Sponsor
- Dr Pranali Laxman Gawade
- Brief Summary
The Present Title "An open labelled clinical trial on preventive and curative effect of Manjishtadi Lotion on Kikkisa w.s.r. to Striae Gravidarum" is a clinical study with total number of 40 registered Primi-gravida divided into 2 groups each 20.
Group A will have 20 Primi-gravida in their 5th and 6th month of pregnancy and Group B will have 20 in their 6th and 7th month of pregnancy.
Group A will be Preventive group and Group B will be Curative group. Both groups will be administered with local application of Manjishtadi Lotion on abdomen thrice a day for two months. Assessment will be done with subjective and objective criteria on 30th and 60th day. Follow up will be on 90th day.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 40
- 1.Primi-gravida with gestational age between 16th to 24th week and having no any symptoms of Kikkisa for Preventive Group.
- 2.Primi-gravida with gestational age between 20th to 28th week and having one or more symptoms or clinical features of Kikkisa for Curative Group.
- 3.Age 18-35 years primi-gravida.
- 1.Multi-gravida.
- 2.Polyhydramnios and Twin pregnancy 3.Pregnancy with huge uterine fibroid or ovarian cyst.
- 4.Pregnant woman suffering from any other skin disease.
- 5.Pregnant woman suffering from any systemic illness.
- 6.Pregnant woman above 40 years of age.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Group A for prevention of Straie Gravidarum Group A will be assessed for 8 weeks (treatment duration 16th to 24th week of pregnancy) Group B will be assessed for 8 weeks (treatment duration 20th to 28th week of pregnancy) Group B to cure Straie Gravidarum Group A will be assessed for 8 weeks (treatment duration 16th to 24th week of pregnancy) Group B will be assessed for 8 weeks (treatment duration 20th to 28th week of pregnancy)
- Secondary Outcome Measures
Name Time Method Group A Striae Gravidarum does not appear at all Group B Cure of the Striae Gravidarum & reduction in the symptoms kandu daha twaka bheda vaivarnya Rekha swaroop twaka sankocha
Trial Locations
- Locations (1)
OPD and IPD, Department of Prasuti Tantra Evum Stree Roga
🇮🇳Belgaum, KARNATAKA, India
OPD and IPD, Department of Prasuti Tantra Evum Stree Roga🇮🇳Belgaum, KARNATAKA, IndiaDr Pranali Laxman GawadePrincipal investigator09518959948plgawade97@gmail.com